Stock News & Analysis

Investors aren't happy with Mesa Labs latest quarterly report.

Berkshire cashed out of UnitedHealth before the recent rally, but that doesn't mean Abel sold too early.

MBX Biosciences, a clinical-stage biotech developing peptide therapies, reported a notable insider sale after a year of rapid stock gains.

Booming demand for energy solutions from hyperscalers is giving these three industrial stocks a massive boost.

Buzz about the company's new wraps seem to be spreading.

One recognizable name in growth investing is eager to continue buying shares of this AI specialist.

The government will invest up to $100 million each in D-Wave, Rigetti, and Infleqtion.

This is a battle between a gold giant generating record cash flows and a smaller miner about to sell its most problematic mine and get $1.5 billion.

MarketAxess sits at the center of the shift toward electronic bond trading and investors are watching whether record activity is turning into deeper client reliance on its trading, data, and automation tools.

Investors are choosing between a bird in the hand versus two in the bush.

Both funds delivered nearly identical returns and yields last year.

The chipmaker has been on an incredible rally, and AI is at the heart of its momentum.

The medical device giant just opened its wallet for a stake in a privately held company with a groundbreaking product.

The same supply crunch behind the memory chipmaker's historic milestone is fueling enormous runs in two storage stocks, too.

Eli Lilly's fundamentals matter more than Trump's stock purchases.

Qfin saw a double-digit sales decline last quarter, but investors are seeing big silver linings.

The tech giant doesn't hit these valuation levels often.

AMD's stock price is growing much faster than the company.

Will Ford's pivot from EVs to energy storage turn out to be a brilliant move?

The Chinese EV maker still has plenty of irons in the fire.